Infographic Summary
Global Factor IX Deficiency Treatment (Hemophilia B) Market size is forecast to increase from $5.58 Billion in 2026 to $9.88 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.
Global Factor IX Deficiency Treatment (Hemophilia B) Market size is forecast to increase from $5.58 Billion in 2026 to $9.88 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.
Global Factor IX Deficiency Treatment (Hemophilia B) Market size is forecast to increase from $5.58 Billion in 2026 to $9.88 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.